Spravato®Registry-verifiedDesignated-centers model

Psychiatriezentrum Münsingen, Standort Münsingen

Münsingen, Switzerland

Treatment & access

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

About this provider

PZM Psychiatriezentrum Muensingen AG, at Hunzigenallee 1 in Muensingen near Bern, is an open competence centre with a psychotherapeutic orientation and clinical focuses on affective disorders, psychotic illness, addiction and geriatric psychiatry. Depression care runs through the Klinik fuer Depression und Angst, which treats depression, anxiety disorders and acute psychiatric illness in an evidence-based, person-centred way, complemented by the Psychotherapiestation Muensingen and outpatient individual therapy. PZM's public pages do not describe an esketamine programme; ask the clinic about eligibility under the Swiss route.

Services & programs

  • Klinik fuer Depression und Angst: evidence-based, person-centred treatment of depression, anxiety disorders and acute psychiatric illness
  • Psychotherapiestation Muensingen (PTM) for depression, anxiety, compulsions, trauma-related and personality disorders
  • Outpatient individual therapy with focus on depression and anxiety disorders
  • Geriatric psychiatry and neuropsychiatry
  • Treatment of psychotic illness and addiction
  • Online patient registration for referrers

Common questions

Does PZM publish an esketamine offer?

No esketamine service page is published on pzmag.ch. PZM appears on the official BAG list of designated Spravato centres, so contact the centre (+41 31 720 81 11, info@pzmag.ch) to ask about esketamine eligibility, the insurer pre-approval (Kostengutsprache) and where treatment takes place.

What are the Swiss reimbursement conditions?

OKP covers Spravato only at BAG-designated centres for adults 18-74 with treatment-resistant depression: at least two adequate antidepressant trials plus one augmentation attempt without sufficient response, CGI-S of 5 or higher, prior insurer approval, and a maximum treatment duration of 10 months.

Looking at alternatives? One of the BAG-designated Spravato centers; see the country guide and the limited-medical-use PAT program.

Verification

At least one source for this record is a public state registry or an official public-law register. The registry entry is linked below and re-checked at least every 90 days.

Spotted an error? See our methodology for how records are checked and how to report a correction.

Check your fit & enquire

Spravato® access in Switzerland follows published criteria. A short pre-screening comes first, then your compiled summary goes to Psychiatriezentrum Münsingen, Standort Münsingen only with your explicit consent, and you can download it for yourself either way.

Why enquire via PsyAccess

  • Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
  • A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
  • Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.
Check my fit & enquire

About two minutes. The check itself runs in your browser: your answers are never sent anywhere unless you choose to send them. We count only anonymous usage events.